A prototype of a one-time-implantable spinal cord stimulation (SCS) system using wireless power and data-transmission techniques is presented in this paper. The power of the implant is induced by wireless coil coupling, and duplex amplitude-shift keying-load-shift keying wireless communication is used so that digital packets can be transmitted by the same inductive link. The proposed novel ASK demodulator attains high demodulation performance and small area without using any resistors and capacitors. The proposed SCS system utilizes many power saving schemes to reduce power dissipation (e.g., dual supply voltages on-chip, high-voltage impulse generation using small current, etc.). Meanwhile, the excess energy induced by the coils is stored in a rechargeable battery to extend the implant's operation time so that the number of battery replacement surgeries will be reduced significantly. The system-on-chip (SOC) is physically implemented on silicon and integrated in the implant as the system controller. The fabricated SOC area is 1410 × 1710 μm(2). Compared with existing commercial products, the proposed SCS system attains better flexibility and longer operation time.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TBCAS.2011.2157152DOI Listing

Publication Analysis

Top Keywords

scs system
12
one-time-implantable spinal
8
spinal cord
8
cord stimulation
8
proposed scs
8
operation time
8
system
5
stimulation system
4
system prototype
4
prototype prototype
4

Similar Publications

Introduction Evoked compound action potentials (ECAPs) during spinal cord stimulation (SCS) may be useful in the treatment of chronic pain as a control signal for closed-loop neuromodulation. However, considerable inter-individual variability in evoked responses requires robust methods in order to realize effective, personalized pain management. These methods include artifact removal, feature extraction, classification, and prediction.

View Article and Find Full Text PDF

Aims: Systemic corticosteroids (SCS) are used to manage asthma exacerbations. Among the broad population of patients with asthma, SCS-related risk of adverse events (AEs), health care resource utilization (HCRU), and costs remain unclear.

Materials And Methods: This retrospective cohort study used the Optum Research Database claims to identify adults with asthma from 1/1/2017-6/30/2022.

View Article and Find Full Text PDF

Spinal cord injury (SCI) represents a significant medical challenge, leading to profound and often debilitating neurological deficits that adversely affect motor, sensory, and autonomic functions. Traditional rehabilitation strategies, while essential in the management of SCI, often exhibit limited efficacy in restoring lost functions, leaving many individuals with permanent disabilities. In this context, spinal cord stimulation (SCS) emerges as a novel and promising therapeutic approach with the potential to enhance neurological recovery by promoting neural plasticity and activating residual neural pathways.

View Article and Find Full Text PDF

Spinal cord stimulation trial-to-implant ratios: relic or requisite?

Reg Anesth Pain Med

March 2025

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.

The trial-to-implant ratio for spinal cord stimulation (SCS) has long served as a cornerstone metric for optimizing patient selection and cost containment. Historically, screening trials played a pivotal role in identifying non-responders, thereby minimizing unnecessary permanent implantations. The utility of the trial paradigm is supported by Medicare data from 2009, which reported a trial-to-implant ratio of 42.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!